MINI REVIEW article
Front. Clin. Diabetes Healthc.
Sec. Diabetes Nephropathy
Volume 6 - 2025 | doi: 10.3389/fcdhc.2025.1570868
This article is part of the Research TopicHighlights in Diabetes NephropathyView all 15 articles
UNDERESTIMATED REASON OF HYPERKALEMIA IN DIABETIC PATIENTS: TYPE ıv RENAL TUBULAR ACIDOSIS-MINI REVIEW
Provisionally accepted
Sibel Ertek1*
Kayser Caglar2*- 1Losante Hospital Dept. Endocrinology, Gölbaşı/Ankara, Türkiye
- 2Losante Hospital, Dept. Nephrology, Ankara-Golbasi, Türkiye
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Diabetes mellitus is chronic disease with increasing prevalance, and may cause many organ complications, including kidneys. Reduced creatinine clearence and kidney failure are important, but hyperkalemia may be present in diabetic patients even before these problems. There may be many reasons of hyperkalemia in this group of patients. Type IV renal tubular acidosis is important cause of generally mild hyperkalemia, and it is a treatable condition. ''Polypharmacy'' -which is very common in diabetic patients due to accompanying other diseases-may trigger electrolyte imbalance. Underlying causes should be investigated and treatment should be done before it worsens.
Keywords: diabetes, Hyperkalemia, Type IV renal tubular acidosis, hyporeninemic hypoaldosteronism, Potassium
Received: 04 Feb 2025; Accepted: 21 May 2025.
Copyright: © 2025 Ertek and Caglar. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Sibel Ertek, Losante Hospital Dept. Endocrinology, Gölbaşı/Ankara, Türkiye
Kayser Caglar, Losante Hospital, Dept. Nephrology, Ankara-Golbasi, Türkiye
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.